Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood

Forskning

Udskriv

Switch language

Rigshospitalet - en del af Københavns Universitetshospital

Udgivet

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Author

Bhattoa, Harjit P ; Cavalier, Etienne ; Eastell, Richard ; Heijboer, Annemieke C ; Jørgensen, Niklas R ; Makris, Konstantinos ; Ulmer, Candice Z ; Kanis, John A ; Cooper, Cyrus ; Silverman, Stuart L ; Vasikaran, Samuel D ; IFCC-IOF Committee for Bone Metabolism. / Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood. I: Clinica chimica acta; international journal of clinical chemistry. 2021 ; Bind 515. s. 16-20.

Bibtex

@article{2c74d31e6e314cefbd7b5e86ff1fd82f,

title = "Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood",

abstract = "Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The IFCC Committee on Bone Metabolism (C-BM) has examined current commercial assays and performed a multicentre study to examine the agreement between assays for PINP and β-CTX in serum and plasma. The results of these studies will inform our work towards the harmonization of PINP assays and the standardization of β-CTX assays in blood, with the development of common calibrators and reference measurement procedures in collaboration with the reagent manufacturing industry. Successful achievement of these goals will help develop universally acceptable practice guidelines for the management of osteoporosis with the inclusion of common reference intervals and treatment targets for PINP and β-CTX.",

keywords = "Bone formation, Bone resorption, Bone turnover markers, C-terminal telopeptide of type I collagen, Harmonization, PINP, Procollagen type I N-propeptide, Standardization, β-CTX",

author = "Bhattoa, {Harjit P} and Etienne Cavalier and Richard Eastell and Heijboer, {Annemieke C} and J{\o}rgensen, {Niklas R} and Konstantinos Makris and Ulmer, {Candice Z} and Kanis, {John A} and Cyrus Cooper and Silverman, {Stuart L} and Vasikaran, {Samuel D} and {IFCC-IOF Committee for Bone Metabolism}",

year = "2021",

month = apr,

doi = "10.1016/j.cca.2020.12.023",

language = "English",

volume = "515",

pages = "16--20",

journal = "Clinica Chimica Acta",

issn = "0009-8981",

publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood

AU - Bhattoa, Harjit P

AU - Cavalier, Etienne

AU - Eastell, Richard

AU - Heijboer, Annemieke C

AU - Jørgensen, Niklas R

AU - Makris, Konstantinos

AU - Ulmer, Candice Z

AU - Kanis, John A

AU - Cooper, Cyrus

AU - Silverman, Stuart L

AU - Vasikaran, Samuel D

AU - IFCC-IOF Committee for Bone Metabolism

PY - 2021/4

Y1 - 2021/4

N2 - Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The IFCC Committee on Bone Metabolism (C-BM) has examined current commercial assays and performed a multicentre study to examine the agreement between assays for PINP and β-CTX in serum and plasma. The results of these studies will inform our work towards the harmonization of PINP assays and the standardization of β-CTX assays in blood, with the development of common calibrators and reference measurement procedures in collaboration with the reagent manufacturing industry. Successful achievement of these goals will help develop universally acceptable practice guidelines for the management of osteoporosis with the inclusion of common reference intervals and treatment targets for PINP and β-CTX.

AB - Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The IFCC Committee on Bone Metabolism (C-BM) has examined current commercial assays and performed a multicentre study to examine the agreement between assays for PINP and β-CTX in serum and plasma. The results of these studies will inform our work towards the harmonization of PINP assays and the standardization of β-CTX assays in blood, with the development of common calibrators and reference measurement procedures in collaboration with the reagent manufacturing industry. Successful achievement of these goals will help develop universally acceptable practice guidelines for the management of osteoporosis with the inclusion of common reference intervals and treatment targets for PINP and β-CTX.

KW - Bone formation

KW - Bone resorption

KW - Bone turnover markers

KW - C-terminal telopeptide of type I collagen

KW - Harmonization

KW - PINP

KW - Procollagen type I N-propeptide

KW - Standardization

KW - β-CTX

UR - http://www.scopus.com/inward/record.url?scp=85099205225&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2020.12.023

DO - 10.1016/j.cca.2020.12.023

M3 - Journal article

C2 - 33382995

VL - 515

SP - 16

EP - 20

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -

ID: 64127535